Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection
- PMID: 23471635
- DOI: 10.1007/s00705-013-1645-3
Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection
Abstract
Today, dengue viruses are the most prevalent arthropod-borne viruses in the world. Since the 1960s, numerous reports have identified a second heterologous dengue virus (DENV) infection as a principal risk factor for severe dengue disease (dengue hemorrhagic fever/dengue shock syndrome, DHF/DSS). Modifiers of dengue disease response include the specific sequence of two DENV infections, the interval between infections, and contributions from the human host, such as age, ethnicity, chronic illnesses and genetic background. Antibody-dependent enhancement (ADE) of dengue virus infection has been proposed as the early mechanism underlying DHF/DSS. Dengue cross-reactive antibodies raised following a first dengue infection combine with a second infecting virus to form infectious immune complexes that enter Fc-receptor-bearing cells. This results in an increased number of infected cells and increased viral output per cell. At the late illness stage, high levels of cytokines, possibly the result of T cell elimination of infected cells, result in vascular permeability, leading to shock and death. This review is focused on the etiological role of secondary infections (SI) and mechanisms of ADE.
Similar articles
-
Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.J Gen Virol. 2010 Feb;91(Pt 2):394-403. doi: 10.1099/vir.0.015420-0. Epub 2009 Oct 14. J Gen Virol. 2010. PMID: 19828759
-
Development of an antibody-dependent enhancement assay for dengue virus using stable BHK-21 cell lines expressing Fc gammaRIIA.J Virol Methods. 2010 Feb;163(2):205-9. doi: 10.1016/j.jviromet.2009.09.018. Epub 2009 Sep 23. J Virol Methods. 2010. PMID: 19781573
-
Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection.Exp Biol Med (Maywood). 2008 Apr;233(4):401-8. doi: 10.3181/0707-MR-198. Exp Biol Med (Maywood). 2008. PMID: 18367628 Review.
-
Dengue virus neutralization and antibody-dependent enhancement activities of human monoclonal antibodies derived from dengue patients at acute phase of secondary infection.Antiviral Res. 2013 Jun;98(3):423-31. doi: 10.1016/j.antiviral.2013.03.018. Epub 2013 Mar 29. Antiviral Res. 2013. PMID: 23545366
-
Dengue hemorrhagic fever with special emphasis on immunopathogenesis.Comp Immunol Microbiol Infect Dis. 2007 Sep;30(5-6):329-40. doi: 10.1016/j.cimid.2007.05.010. Epub 2007 Jul 23. Comp Immunol Microbiol Infect Dis. 2007. PMID: 17645944 Review.
Cited by
-
Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis.Mol Immunol. 2022 Dec;152:172-182. doi: 10.1016/j.molimm.2022.11.010. Epub 2022 Nov 10. Mol Immunol. 2022. PMID: 36371813 Free PMC article. Review.
-
Vaccine-associated enhanced disease in humans and animal models: Lessons and challenges for vaccine development.Front Microbiol. 2022 Aug 10;13:932408. doi: 10.3389/fmicb.2022.932408. eCollection 2022. Front Microbiol. 2022. PMID: 36033843 Free PMC article. Review.
-
Efficacy of Dengue Vaccines in the Prevention of Severe Dengue in Children: A Systematic Review.Cureus. 2022 Sep 7;14(9):e28916. doi: 10.7759/cureus.28916. eCollection 2022 Sep. Cureus. 2022. PMID: 36225478 Free PMC article. Review.
-
Primary exposure to Zika virus increases risk of symptomatic dengue virus infection with serotypes 2, 3, and 4 but not serotype 1.medRxiv [Preprint]. 2023 Nov 30:2023.11.29.23299187. doi: 10.1101/2023.11.29.23299187. medRxiv. 2023. Update in: Sci Transl Med. 2024 May 29;16(749):eadn2199. doi: 10.1126/scitranslmed.adn2199 PMID: 38077039 Free PMC article. Updated. Preprint.
-
Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy.Arch Virol. 2016 Jul;161(7):1751-60. doi: 10.1007/s00705-016-2855-2. Epub 2016 Apr 11. Arch Virol. 2016. PMID: 27068162 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
